Dicerna Pharmaceuticals
DRNA
#4022
Rank
S$3.83 B
Marketcap
S$49.24
Share price
0.00%
Change (1 day)
16,272.72%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: S$3.83 Billion

As of January 2026 Dicerna Pharmaceuticals has a market cap of S$3.83 Billion. This makes Dicerna Pharmaceuticals the world's 4022th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022S$3.99 B-0.84%
2021S$4.02 B82.33%
2020S$2.20 B3.86%
2019S$2.12 B113.39%
2018S$0.99 B59.72%
2017S$0.62 B621.03%
2016S$86.5 M-74.98%
2015S$0.34 B-10.67%
2014S$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
S$0.72 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$12.16 B 217.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$186.57 B 4,763.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$61.91 B 1,514.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$355.72 B 9,172.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$228.77 B 5,863.30%๐Ÿ‡บ๐Ÿ‡ธ USA